Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphohistiocytosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kim E. Nichols, MD
St. Jude Children's Research Hospital
Study Chair - Melissa Hines, MD
St. Jude Children's Research Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Children'S Hospital of Orange County
Orange, California, United States
- University of California San Francisco
San Francisco, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- John Hopkins University
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Cohen Children'S Medical Center
New Hyde Park, New York, United States
- Levine Children'S Hospital
Charlotte, North Carolina, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Children'S Wisconsin/medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jul 2021
- Primary completion
- 7 Nov 2025
- Completion
- 31 Aug 2026
- Last update posted
- 24 Apr 2026
- Registered enrollment
- 10
- Registry id
- NCT04551131
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.